Woodstock, GA – April 14, 2015 – The February 2015 issue of Healthcare Purchasing News included an interview with Marc Waldman (NeoMed Director of Business Development) describing enteral device technology and the impact on nutrition delivery. The article’s focus is on reduced readmissions and improved clinical outcomes through correct diagnosis and proper nutrition. Contributing to that is the significant impact syringe design has on critical lipid delivery to the Neonatal Patient. Marc states in the article that “A significant focus for NeoMed has been to demonstrate that our enteral devices work to preserve the macro/micro nutrients vital for the development of the micro-preemie to term patient. Morbidity is significantly reduced by patients that reach a return to birth weight within 14 days.” For additional details and to read the full article visit http://www.hpnonline.com/inside/2015-02/1502-OR-Nutrition.html